ESO Advanced Breast Cancer Third International Consensus Conference
Oncology Meeting Resources
05 Nov - 07 Nov, Lisboa, Portugal
The primary aims of ESO Advanced Breast Cancer Third International Consensus Conference was the development of international consensus guidelines for the management of ABC patients, to improve outcomes for all patients with advanced breast cancer.
It aimed also to identify research priorities based on the most important areas of unmet need; analyse and discuss available data to provide the most accurate management recommendations, but also to influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life.
Presentations from the Meeting are now available here. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.
|Presenter||Presentation title||Session title|
|F. Cardoso, PT||Main findings of the mBCVision 2025 Project||Breast cancer patient advocacy session: Worldwide survey and call to action|
|D. Spence, AU||What are the requirements to assist women to address these issues?||Breast cancer patient advocacy session: Specific issues of young women with advanced breast cancer|
|E. Papadopoulos, CY||Empowering women||Breast cancer patient advocacy session: Specific issues of young women with advanced breast cancer|
|F. Cardoso, PT||Opening and introduction||Opening session|
|D. “CJ” M. Corneliussen-James, US||Keynote lecture: METAvivor: fighting prejudice!||Opening session|
|S. M. Swain, US||Is there and optimal treatment sequence?||Optimal management of HER-2+ ABC|
|I. E. Krop, US||Resistance to anti-HER-2 agents: what's new||Optimal management of HER-2+ ABC|
|K. Gelmon, CA||Long term survivors specific issues||Optimal management of HER-2+ ABC|
|A. Eniu, RO||Endocrine||New drugs, new side effects|
|H. S. Rugo, US||Pulmonary||New drugs, new side effects|
|C. H. Barrios, BR||Immunologic alterations||New drugs, new side effects|
|L. Fallowfield, UK||The role of Patient Reported Outcomes||New drugs, new side effects|
|R. E. Coleman, UK||Living with metastatic bone disease – the positive impact of bone-targeted treatments||ABC Award and Lecture|
|A. Eniu, RO||Pain medication: Is it universally available to ABC Patients? Is it a patient and/or human right in ABC?||Breast cancer patient advocacy session: Advanced breast cancer sympton control|
|L. Fallowfield, UK||Barriers to active patient reporting of Quality of Life symptoms/outcomes in the ABC setting||Breast cancer patient advocacy session: Advanced breast cancer sympton control|